Mutation distribution in expanded screening for cystic fibrosis: Making up the balance in a context of ethnic diversity

Clinical Chemistry

Volumn 57, Issue 6, 2011, Pages 799-801

  Schrijver, Iris ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ASIAN; CAUCASIAN; CYSTIC FIBROSIS; EDITORIAL; ETHNICITY; EXON; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HISPANIC; HUMAN; MISSENSE MUTATION;

AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC TESTING; HETEROZYGOTE DETECTION; HISPANIC AMERICANS; HUMANS; MUTATION;

EID: 79957722641     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.164673     Document Type: Editorial

References (16)

1. Cystic Fibrosis Foundation. Patient registry report. http://www.cff.org/ research/ClinicalResearch/PatientRegistryReport (Accessed March 2011).
2. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:3-8.
3. Abeliovich D, Lavon IP, Lerer I, Cohen T, Springer C, Avital A, Cutting GR. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992;51:951-6.
4. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ (Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-54.
5. Palomaki GE, FitzSimmons SC, Haddow JE. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Genet Med 2004;6:405-14. (Pubitemid 39304378)
6. Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998;132:255-9. (Pubitemid 28125176)
7. Cystic fibrosis mutation database. http://www.genet.sickkids.on.ca/cftr/ (Accessed March 2011).
8. Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, et al. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat 2004;24:353; erratum 2005;25:223.
9. Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among U.S. Hispanics and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med 2004;6:392-9.
10. Schrijver I, Rappahahn K, Pique L, Kharrazi M, Wong L-J. Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis. J Mol Diagn 2008;10:368-75. (Pubitemid 352019124)
11. Carles S, Desgeorges M, Goldman A, Thiart R, Guittard C, Kitazos CA, et al. First report of CFTR mutations in black cystic fibrosis patients of southern African origin. J Med Genet 1996;33:802-4. (Pubitemid 26302501)
12. American College of Obstetricians and Gynecologists (ACOG). Preconception and prenatal carrier screening for CF: clinical and laboratory guidelines. Washington, (DC): ACOG; 2001.
13. Watson M, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004;6:387-91.
14. Grody WW, Cutting GR, Watson MS. The cystic fibrosis mutation "arms race": when less is more. Genet Med 2007;9:739-44.
15. Rohlfs EM, Zhou Z, Heim RA, Nagan N, Rosenblum LS, Flynn K, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem 2011;57:841-8.
16. Strom CM, Crossley B, Buller-Buerkle A, Jarvis M, Quan F, Peng M, et al. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis. Genet Med 2011;11:166-72.